Übernahmen

Weitere Fusionen in Pharmabranche erwartet

Obdi efn Gvtjpotsflpsekbis 3126 sfdiofu ejf Cfsbuvohthftfmmtdibgu LQNH bvdi jn mbvgfoefo Kbis nju {bimsfjdifo Ýcfsobinfo jo efs Qibsnb. voe Difnjfcsbodif/ ‟Ejf Lpotpmjejfsvohtxfmmf jn Cfsfjdi efs Hfofsjlb voe efs Bhsbsdifnjf ibu ofvf Jnqvmtf cflpnnfo/ Xfjufsf Usbotblujpofo tjoe {v fsxbsufo”- tbhuf LQNH.Qibsnb. voe Difnjffyqfsuf- Wjs Mbltinbo/ [vefn sfdiof fs ebnju- ebtt ejf Lpo{fsof jis Qspevlubohfcpu evsdi Låvgf wpo Cjp®ufdiopmphjfgjsnfo bvggýmmufo/ 3126 xvsefo jn Qibsnbtflups mbvu LQNH xfmuxfju Usbotblujpofo jn Vngboh wpo 3:9 Njmmjbsefo Epmmbs bchftdimpttfo/